Top Markets
#1 MowCat MowCat +48.93%
#2 Velvet Velvet +23.57%
#3 Derive Derive +21.01%
#4 Quack AI Quack AI +20.19%
#5 Bermuda Shorts Bermuda Shorts +15.80%
#6 MarsCoin MarsCoin +15.17%
#7 Geodnet Geodnet +14.36%
#8 Audiera Audiera +13.55%
#9 Cross Cross +13.10%
#10 aPriori aPriori +12.66%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
株式のランク #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
株価
$1.85
最終同期: 2024-08-19
時価総額
$3.96M
変化（1日）
2.78%
変化（1年）
0.00%
国
US
取引 MyMD Pharmaceuticals, Inc. (MYMD)

カテゴリー

Healthcare
MyMD Pharmaceuticals, Inc.（MYMD）の収益
Aug 2026 時点の収益 TTM: 0
MyMD Pharmaceuticals, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
MyMD Pharmaceuticals, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE